THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION

Volker Pönitz; Heidi Grundt; Barbara Bottazzi; Ivan Cuccovillo; Alberto Mantovani; Dennis W Nilsen

doi:10.1016/s0735-1097(13)60186-2

Related publications

Article2018

LONG-TERM SURVIVAL AFTER MYOCARDIAL INFARCTION IN A SIX-YEAR FOLLOW-UP COHORT, EOLE

Nicholas Moore, C. Droz‐Perroteau, Patrick Blin, C. Dureau‐Pournin, Daniel Thomas, Nicolas Danchin, J Tricoire, François Paillard, Serge Hercberg, Marie‐Agnès Bernard, Jacques Bénichou

Article2012

Abstract 13464: Pentraxin 3 is Uninfluenced by High Doses of Concentrated Omega-3 Fatty Acids Administered for 12 Months Following an Acute Myocardial Infarction

Volker Poenitz, Heidi Grundt, Barbara Bottazzi, Ivan Cuccovillo, Alberto Mantovani, Dennis W Nilsen

Article2021

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Piero Clavario, Vincenzo De Marzo, Roberta Lotti, Cristina Bárbara, Annalisa Porcile, Carmelo Russo, Federica Beccaria, Marco Bonavia, Luigi Carlo Bottaro, Marta Caltabellotta, Flavia Chioni, Monica Santangelo, Arto J. Hautala, Raffaele Griffo, Gianfranco Parati, Ugo Corrà, Italo Porto

Article2021

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Vincenzo De Marzo, Piero Clavario, Roberta Lotti, Cristina Bárbara, Annalisa Porcile, G Guglielmi, C Allison Russo, A J Autala, Raffaele Griffo, Gianfranco Parati, Ugo Corrà, Italo Porto

Article2004

Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction

Roberto Latini, Aldo Maggioni, Giuseppe Peri, Lucio Gonzini, Donata Lucci, Paolo Mocarelli, Luca Vago, Fabio Pasqualini, Stefano Signorini, Dario Soldateschi, Lorenzo Tarli, Carlo Schweiger, Claudio Fresco, Rossana Cecere, Gianni Tognoni, Alberto Mantovani

THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION

Discussion(0)

Related publications

LONG-TERM SURVIVAL AFTER MYOCARDIAL INFARCTION IN A SIX-YEAR FOLLOW-UP COHORT, EOLE

Abstract 13464: Pentraxin 3 is Uninfluenced by High Doses of Concentrated Omega-3 Fatty Acids Administered for 12 Months Following an Acute Myocardial Infarction

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction